Is stopping secondary prophylaxis safe in HIV‐positive talaromycosis patients? Experience from Myanmar

OBJECTIVES: The aim of the study was to determine whether it is safe to stop secondary prophylaxis in patients with talaromycosis after immune reconstitution with a sustained increase in CD4 count to ≥ 100 cells/µL after antiretroviral therapy (ART). METHODS: A retrospective cohort analysis was perf...

Descripción completa

Detalles Bibliográficos
Autores principales: Tun, N, Mclean, A, Deed, X, Hlaing, M, Aung, Y, Wilkins, E, Ashley, E, Smithuis, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590157/
https://www.ncbi.nlm.nih.gov/pubmed/32741092
http://dx.doi.org/10.1111/hiv.12921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590157/
https://www.ncbi.nlm.nih.gov/pubmed/32741092
http://dx.doi.org/10.1111/hiv.12921

Ejemplares similares